Found vs SkinnyRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

53 providers verified independently·Independent researchHow we rank →

Found beats SkinnyRx overall, scoring 7.3/10 vs 5.3/10. Found is more affordable at $129/mo vs $199/mo. Choose Found for insured patients who want their glp-1 coverage checked and t. Choose SkinnyRx for users who want flexibility in compounded glp-1 medication fo.

A side-by-side look at Found and SkinnyRx to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for
Higher Rated

Found

#33 of 53
7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found

SkinnyRx

#48 of 53
5.3/10

Direct-to-consumer telehealth platform offering compounded GLP-1 medications across five formats, injectable and sublingual semaglutide, semaglutide tablets, and tirzepatide as either injectable or tablets. Operated by Lean Rx, Inc. (Sacramento, CA). Compounded only, does not prescribe brand-name Wegovy/Zepbound/Ozempic/Mounjaro. Cash-pay only with HSA/FSA accepted; does not bill insurance. 4,100+ Trustpilot reviews at 4.8 stars.

Visit SkinnyRx
FeatureFoundSkinnyRx
Why each oneOne of the only GLP-1 platforms that actively coordinates with insurance companies, offers a GLP-1 coverage check, and prescribes from 10+ medications.The broadest compounded-GLP-1 menu in DTC telehealth, five medication formats including the uncommon sublingual semaglutide and even rarer oral tirzepatide tablets. Most competitors offer one or two formats; SkinnyRx covers every administration route a compounded patient might prefer.
Our Score7.3/105.3/10
Starting Price$129/mo$199/mo
Medication TypeBothCompounded
Insurance AcceptedYesNo
Best ForInsured patients who want their GLP-1 coverage checked and their copay minimizedUsers who want flexibility in compounded GLP-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point
Watch out forCosts vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before payingNo brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro), so patients who want or need an FDA-approved finished product should buy elsewhere
Ranking#33#48
Get startedVisit FoundVisit SkinnyRx

Pros & Cons Compared

Found

Pros

  • +Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
  • +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
  • +Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives
  • +Most members start treatment within one week of completing the health questionnaire

Cons

  • Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
  • The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
  • Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does

SkinnyRx

Pros

  • +Five medication formats, the broadest compounded-GLP-1 menu in DTC telehealth, including the rare oral tirzepatide tablet that almost no competitor offers
  • +$199/mo entry price for both injectable and sublingual semaglutide is competitive in the mid-tier compounded segment
  • +Fast onboarding: 5-10 minute online questionnaire, physician review in 24-48 hours, medication delivered in 3-7 business days with temperature-controlled shipping
  • +4,100+ Trustpilot reviews at 4.8 stars, among the strongest aggregate social-proof signals in the GLP-1 telehealth category

Cons

  • No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro), so patients who want or need an FDA-approved finished product should buy elsewhere
  • Light public disclosure: founders, executive team, medical director, and specific compounding-pharmacy partners are not named on the public site, ask support before enrolling if provenance matters to you
  • Cash-pay only, does not bill commercial insurance, Medicare, or Medicaid. HSA/FSA payments are accepted, which is the main way to soften the cost.
  • Independent reviews flag inconsistent customer-service responsiveness, a real consideration since titration support and dose adjustments run through chat

Our Verdict

Found edges out SkinnyRx with a score of 7.3/10 vs 5.3/10. If budget is your priority, Found is from $129/mo compared to SkinnyRx from $199/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: insured patients who want their glp-1 coverage checked and their copay minimized. Choose SkinnyRx if you want: users who want flexibility in compounded glp-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point.

Cheapest in our index

Embody

$69/mo flat rate · 7.3/10 · Compounded

Both Found and SkinnyRx start above the cheapest program we track. Across all 53 providers in our index, that floor is Embody at a flat $69/mo, the same rate at every dose, price checked July 31, 2026. It scores 7.3/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.

Try Found

Starting at $129/mo

Visit Found

Try SkinnyRx

Starting at $199/mo

Visit SkinnyRx

Related comparisons

Other matchups readers comparing Found or SkinnyRx tend to look at next.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Our pick of these two: Found · 7.3/10